TCF1 and Tox define different subsets of CD4 T cells in patients with Sézary syndrome
Leuk Lymphoma
.
2022 Nov;63(11):2715-2718.
doi: 10.1080/10428194.2022.2081326.
Epub 2022 Jun 9.
Authors
Maria Wysocka
1
,
Neha Jariwala
1
,
Kevin Zhang
2
,
Bernice Benoit
3
,
Alain H Rook
1
Affiliations
1
Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
2
Department of Dermatology, The Ohio State University College of Medicine and Public Health, Columbus, OH, USA.
3
Department of Pathology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
PMID:
35679527
DOI:
10.1080/10428194.2022.2081326
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
CD4-Positive T-Lymphocytes
Humans
Lymphoma, T-Cell, Cutaneous*
Sezary Syndrome* / diagnosis
Skin Neoplasms*
Grants and funding
R01 AR074797/AR/NIAMS NIH HHS/United States
R01 CA238552/CA/NCI NIH HHS/United States
R01 CA251764/CA/NCI NIH HHS/United States